| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.7M | +139.1% |
| SG&A Expense | $2.3M | -7.6% |
| Operating Income | -$7.1M | -60.3% |
| Net Income | -$7.1M | -60.0% |
| EPS (Basic) | $0.38 | +31.0% |
| EPS (Diluted) | $0.38 | +31.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.5M | +94.3% |
| Current Assets | $4.9M | +104.6% |
| Total Assets | $4.9M | +101.2% |
| Current Liabilities | $1.5M | +49.3% |
| Total Liabilities | $1.7M | +41.4% |
| Stockholders' Equity | $3.2M | +159.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | -75.9% |
| Capital Expenditures | $1K | +0.0% |
| Investing Cash Flow | $1K | +0.0% |
| Financing Cash Flow | $8.7M | — |
| Free Cash Flow | -$6.6M | -75.8% |